Acylated pregnane glycosides from Caralluma quadrangula.

Area of Science:

• Phytochemistry
• Natural Products Chemistry
• Pharmacology

Background:

• The Saudi Arabian plant Caralluma quadrangula (Forssk.) N.E.Br. has demonstrated potential in prior studies.
• Previous research indicated significant in vitro cytotoxic activity of its extracts against breast cancer (MCF7) cell lines.

Purpose of the Study:

• To isolate and characterize bioactive compounds from the chloroform fraction of C. quadrangula.
• To evaluate the cytotoxic potential of isolated compounds against breast cancer (MCF7) cells.

Main Methods:

• Biologically-guided fractionation of the chloroform extract of C. quadrangula aerial parts.
• Structure elucidation of isolated compounds using Mass Spectrometry (MS) and Nuclear Magnetic Resonance (NMR) data.
• In vitro cytotoxic activity testing against the breast cancer (MCF7) cell line.

Main Results:

• Four acylated pregnane glycosides were successfully isolated and identified.
• The isolated compounds were characterized as 12,20-di-O-benzoylboucerin 3-O-β-D-digitoxopyranosyl-(1→4)-β-D-canaropyranosyl-(1→4)-β-D-cymaropyranoside (1), 12,20-di-O-benzoylboucerin 3-O-β-D-cymaropyranosyl-(1→4)-β-D-canaropyranosyl-(1→4)-β-D-cymaropyranoside (2), 12,20-di-O-benzoylboucerin 3-O-β-D-glucopyranosyl-(1→4)-β-D-digitoxopyranosyl-(1→4)-β-D-canaropyranosyl-(1→4)-β-D-cymaropyranoside (3), and 12,20-di-O-benzoyl-3β,5α,12β,14β,20-pentahydroxy-(20R)-pregn-6-ene 3-O-β-D-glucopyranosyl-(1→4)-β-D-digitoxopyranosyl-(1→4)-β-D-canaropyranosyl-(1→4)-β-D-cymaropyranoside (4).
• All four isolated compounds were evaluated for their cytotoxic effects on the MCF7 breast cancer cell line.

Conclusions:

• The study successfully isolated and identified four acylated pregnane glycosides from C. quadrangula.
• These compounds represent potential leads for the development of novel breast cancer therapeutics.
• Further investigation into the mechanism of action and in vivo efficacy is warranted.